The linearly decreasing convergence factor a. by Junhao Wei (6816803)

Effective contact rate over time for the different modelling scenarios considered: fixed, continuously increasing, continuously decreasing and with a step-decrease. by Joshua Looker (21390948)

“…<p>Effective contact rate over time for the different modelling scenarios considered: fixed, continuously increasing, continuously decreasing and with a step-decrease.</p>…”

Includes a file with the results on step parameters. by Sanne Ettema (18786312)

Disturbance of coherent behaviour leads to a decrease in information transfer. by Hannah Zoller (19688084)

Naringenin decreases mitochondrial function. by Lauren A. Eanes (20995499)

Baseline patient characteristics. by Oscar F. C. van den Bosch (22184246)

“…In contrast, s-ketamine appeared to produce a smaller decrease in VTV (ß = −0.062, 95% CI: −0.118 to −0.003) with VRR remaining unaffected (ß = −0.036, 95% CI: −0.092 to 0.019). …”

Includes a file with results on electromyography. by Sanne Ettema (18786312)

Naringenin decreases total cell viability. by Lauren A. Eanes (20995499)

Distribution of Patient-centered care scores as a function of Time. by Thales Guardia de Barros (22216025)

Subjects:

Boxplot of Patient-centered care scores as a function of Time. by Thales Guardia de Barros (22216025)

Subjects:

Table1_Leukocyte telomere length decreased the risk of mortality in patients with alcohol-associated liver disease.docx by Jiahong Yi (14481735)

“…LTL might be a useful biomarker for prognosis among patients with ALD. …”

Comparison of serum VEGF-A165 concentrations pre-bevacizumab administration in patients with increased VEGF-A post-bevacizumab administration and those with decreased VEGF-A. by Masashi Okawa (8951294)

Subjects:

DYRK1A activity on HBV transcription regulatory regions. by Florentin Pastor (19852287)

Subjects:

Effects of bevacizumab addition on VEGF-A concentrations <i>in vitro</i>. by Masashi Okawa (8951294)

Subjects:

Maximum IFN concentrations are decreased in severe patients. by Sonia T. Gazeau (21512764)

Knock-down of DYRK1A decreases HBV RNAs levels in HBV-infected dHepaRG cells. by Florentin Pastor (19852287)

Subjects:

Decrease of cellular cAMP levels in response to a concentration range of melatonin treatments. by Cathryn S. D. Maienza (20629929)

Table 1_Increased frequencies of human Th-17 CD4+ T-cells and decreased T-regulatory cells in patients with early and advanced metabolic dysfunction-associated steatotic liver disease.docx by Elżbieta Supruniuk (16736637)

Table 2_Increased frequencies of human Th-17 CD4+ T-cells and decreased T-regulatory cells in patients with early and advanced metabolic dysfunction-associated steatotic liver disease.xlsx by Elżbieta Supruniuk (16736637)

Linear regression analysis. by Young Kyu Lee (14076058)

Subjects: